Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

TransMedics (TMDX) Return on Capital Employed (2019 - 2026)

TransMedics has reported Return on Capital Employed over the past 7 years, most recently at 2.46% for Q4 2025.

  • For Q4 2025, Return on Capital Employed fell 264.0% year-over-year to 2.46%; the TTM value through Dec 2025 reached 2.46%, down 264.0%, while the annual FY2025 figure was 2.67%, 273.0% down from the prior year.
  • Return on Capital Employed for Q4 2025 was 2.46% at TransMedics, down from 11.44% in the prior quarter.
  • Over five years, Return on Capital Employed peaked at 11.44% in Q3 2025 and troughed at 43.07% in Q2 2022.
  • A 5-year average of 10.2% and a median of 5.21% in 2023 define the central range for Return on Capital Employed.
  • Biggest five-year swings in Return on Capital Employed: plummeted -2208bps in 2022 and later soared 3972bps in 2023.
  • Year by year, Return on Capital Employed stood at 35.91% in 2021, then surged by 65bps to 12.46% in 2022, then soared by 64bps to 4.47% in 2023, then soared by 214bps to 5.1% in 2024, then tumbled by -52bps to 2.46% in 2025.
  • Business Quant data shows Return on Capital Employed for TMDX at 2.46% in Q4 2025, 11.44% in Q3 2025, and 9.48% in Q2 2025.